Tuesday, September 2, 2008

Market Daily -- 2nd Sep 08

29. SGX Off 2.6%; Low Mkt Volumes Bad News-Analyst

28. OCBC maintains SingTel at Buy with target price of S$3.85

27. Research firm Gartner Inc. (IT) has reduced its 2008 and 2009 revenue growth forecast for the semiconductor industry and doesn't expect the sector to recover until the second half of next year

26. UOB Target Cut To S$22.30 From S$23.30 By DMG; Buy Kept

25. OCBC Target Cut To S$9.60 From S$10 By DMG; Buy Kept

24. DBS Target Cut To S$18.80 From S$19.80 By DMG; Neutral Kept

23. Chip Eng Seng Gets S$156M Contract For Residential Buildings

22. Temasek Offers To Arrange Financing For Senoko Buyer -Sources

21. DBS Vickers upgrades China Sky Chemical Fibre to Buy from Hold, target price unchanged at S$0.96

20. Fibrechem Target Cut To S$0.65 From S$1.30 By DBS Vickers

19. The Thai state of emergency sent the baht lower and weighed on Southeast Asia markets Tuesday, though analysts doubted the contagion would last long

18. China XLX Target Cut To S$0.99 from S$1.17 By DMG; Keeps Buy

17. Singapore industrial REITs bucking downward trend in property market as their end markets are more robust, says UOB KayHian

16. S'pore Shares Holding Up Despite Thai Crisis

15. Fuel prices remain a key swing factor for Singapore land transport plays, says JP Morgan

14. Singapore property heavyweights underperforming wider market yet again as worries over softer residential property market continue to weigh

13. Ho Bee Target Cut To S$1.30 From S$1.45 By UOB-KH; Keeps Buy

12. Olam +1.0%; Growth Momentum Sustainable - CS

11. Singapore telco stocks remain key defensive plays amid current equity market uncertainty, says OCBC Investment Research; maintains Overweight rating on sector

10. Cosco Singapore Target Cut To S$2.95 From S$4.29 By CIMB

9. S'pore Banks Look Cheap, Fundamentals Sound -DB

8. Swiber Holdings Target Cut To S$2.17 From S$3.37 By DMG

7. Ezra Hldgs Target Cut To S$2.30 From S$3.21 By DMG; Buy Kept

6. Biosensors may head tad higher after medical products firm says trial that pitted its BioMatrix stent against Johnson & Johnson's rival Cypher stent showed BioMatrix stent was as safe and effective as Cypher's

5. Morgan Stanley downgrades Cosco Corp. to Equalweight from Overweight; slashes price target to S$2.60 from S$4.20

4. Singapore Petroleum Co. may slip on profit-taking following pullback in oil prices overnight

3. STI May Edge Up On Oil Cue But 2750 To Cap For Now

2. ST Engineering May Edge Up On S$112M Contract Win

1. SP AusNet Cut To Neutral From Outperform By Credit Suisse